Akkaraju Srinivas

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Akkaraju Srinivas
CIK #0001253170
EDGAR Form CIK 2011 - 2026
3 [0001253170]
4 [0001253170]
SC 13D [0001253170]
Form 13D/13G Filer Form 13D/13G Subject Filed
Akkaraju Srinivas Versartis Inc [2018-06-18]
Form 3/4/5 Subject 2011 - 2026
Alumis Inc
Akkaraju Srinivas
vTv Therapeutics Inc
Scholar Rock Holding Corp
Kalaris Therapeutics Inc
Samsara BioCapital LP
Samsara Opportunity Fund GP LLC
Samsara BioCapital GP LLC
Samsara Opportunity Fund LP
Mineralys Therapeutics Inc
Aquinox Pharmaceuticals Inc
Syros Pharmaceuticals Inc
CARGO Therapeutics Inc
Intercept Pharmaceuticals Inc
Chinook Therapeutics Inc
Jiya Holding Co LLC
Jiya Acquisition Corp
LENZ Therapeutics Inc
436 LP
Seattle Genetics Inc /WA
Aravive Inc
Principia Biopharma Inc
aTYR Pharma Inc
ZS Pharma Inc
Powell Michael
Sofinnova Management VIII LLC
Sofinnova Venture Partners VIII LP
Aclaris Therapeutics Inc
Healy James
Synlogic Inc
Mehra Anand
Sofinnova Management IX LLC
Sofinnova Venture Partners IX LP
Spark Therapeutics Inc
Histogenics Corp
Alimera Sciences Inc
New Leaf Venture Partners LLC
Delagardelle Jeani
New Leaf Venture Partners LLC
Niedel James
Lathi Vijay K
Chambon Philippe O
Marshall Edwards Inc
Hunt Ronald
New Leaf Venture Partners LLC
World Heart Corp
Durata Therapeutics Inc
Synageva Biopharma Corp
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Mineralys Therapeutics Inc MLYS
Common Stock
2026-02-19 Grant 6,200 $0.00
Mineralys Therapeutics Inc MLYS
Stock Option · derivative
2026-02-19 Grant 8,300 $0.00
Alumis Inc ALMS
Common Stock
2026-01-09 Buy 588,235 $17.00 9,999,995
Kalaris Therapeutics Inc KLRS
Common Stock
2025-12-22 Grant 1,500,000 $10.00 15,000,000
Kalaris Therapeutics Inc KLRS
Common Stock
2025-12-18 Buy 479,847 $10.42 5,000,006
Scholar Rock Holding Corp SRRK
Warrants to Purchase Common Stock · derivative
2025-12-12 Option exercise 1,064,804 $0.00
Scholar Rock Holding Corp SRRK
Common Stock
2025-12-12 Option exercise 1,064,804 $7.35 7,826,309
Alumis Inc ALMS
Common Stock
2025-12-05 Buy 64,969 $8.95 581,473
Alumis Inc ALMS
Common Stock
2025-12-05 Buy 70,028 $10.01 700,980
Alumis Inc ALMS
Common Stock
2025-12-05 Buy 51,380 $10.73 551,307
Alumis Inc ALMS
Common Stock
2025-12-04 Buy 66,027 $8.18 540,101
Alumis Inc ALMS
Common Stock
2025-12-03 Buy 100,000 $7.75 775,000
Alumis Inc ALMS
Common Stock
2025-12-02 Buy 96,000 $7.55 724,800
Alumis Inc ALMS
Common Stock
2025-12-01 Buy 86,350 $7.46 644,171
Alumis Inc ALMS
Common Stock
2025-11-28 Buy 38,702 $7.64 295,683
Alumis Inc ALMS
Common Stock
2025-11-26 Buy 48,537 $7.64 370,823
Alumis Inc ALMS
Common Stock
2025-11-20 Buy 125,743 $7.20 905,350
Alumis Inc ALMS
Common Stock
2025-11-19 Buy 137,772 $6.56 903,784
Alumis Inc ALMS
Common Stock
2025-11-18 Buy 102,652 $6.05 621,045
Alumis Inc ALMS
Common Stock
2025-11-17 Buy 914 $5.51 5,036
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com